The Nucleic Acid Amplification Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Nucleic Acid Amplification Testing Market?
The global market size for nucleic acid amplification testing has seen significant growth recently. The market size is projected to increase from $9.56 billion in 2024 to $11.03 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Nucleic Acid Amplification Testing Industry?
The Nucleic Acid Amplification Testing market is projected to reach a size of $19.26 billion in 2029, growing at a compound annual growth rate of 15.0%.
Download Your Free Sample of the 2025 Nucleic Acid Amplification Testing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Nucleic Acid Amplification Testing Market?
The key drivers in the nucleic acid amplification testing market are:
• Rising incidence of infectious diseases
• Greater need for large-scale testing capabilities
• Increased investments from private companies
• Growing demand for rapid and precise diagnostics methods
Global Market Segmentation: Identifying Major Nucleic Acid Amplification Testing Industry Segments
The nucleic acid amplification testingmarket covered in this report is segmented –
1) By Type: Target Amplification Systems, Probe Amplification Systems, Signal Amplification Systems
2) By Product Type: Consumables, Instruments Or Systems
3) By Technology: Polymerase Chain Reaction (PCR) Tests, Isothermal Nucleic Acid Amplification Technology (INAAT) Tests, Ligase Chain Reaction (LCR) Tests
4) By Application: Infectious Disease Testing, Oncology Testing, Genetic And Mitochondrial Disease Testing, Other Applications
5) By End-Use: Hospitals, Diagnostic Laboratories, Biotechnology Companies, Other End-Users
Pre-order the 2025 Nucleic Acid Amplification Testing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Nucleic Acid Amplification Testing Market?
The key trends in the nucleic acid amplification testing market are:
• The integration of artificial intelligence in the nucleic acid amplification testing is an emerging trend.
• Advancements in wearable and implantable devices are increasingly shaping the future of the market.
• The growing adoption of point-of-care testing is a significant trend in the market.
• Expansion in personalized medicine and integration with digital health technologies is a burgeoning trend shaping the future of the market.
Who Are the Top Competitors & Leading Players in the Nucleic Acid Amplification Testing Market?
Major companies in the nucleic acid amplification testing market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Merck KGaA
• Siemens Healthineers
• Becton, Dickinson and Company
• Laboratory Corporation of America Holdings
• Quest Diagnostics
• Agilent Technologies Inc.
• Grifols S.A.
• Hologic Inc.
• bioMerieux SA
• QuidelOrtho Corporation
• Bio-Rad Laboratories Inc.
• Cepheid Inc.
• GenScript Biotech Corporation
• ARUP Laboratories
• BGI Group
• Promega Corporation
• Meridian Bioscience Inc.
• Takara Bio Inc.
• Eiken Chemical Co. Ltd.
• New England Biolabs Inc.
• TwistDx Limited
• Bioneer Corporation
Regional Dominance: Which Area Leads the Global Nucleic Acid Amplification Testing Market?
North America was the largest region in the nucleic acid amplification testing (NAAT) market in 2024
